Emergent BioSolutions(us:EBS)

    8.08

    -0.25%

    Updated on 2024-12-23

    Open:8.03
    Close:8.08
    High:8.18
    Low:7.83
    Pre Close:8.10
    Volume:553297.00
    Amount:4.45M
    Turnover:1.02%
    Shares:54.18M
    MarketCap:437.63M

    About Emergent BioSolutions Company

    Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

    Company Name: Emergent BioSolutions
    Company Address: 300 Professional Drive,Suite 400
    Employees: 1600
    Fiscar Year: 12-31
    IPO Date: 2009-10-02
    CIK: 1367644

    View all SEC Filings

    About

    Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
    Address:300 Professional Drive,Suite 400
    Website:http://www.emergentbiosolutions.com

    Market Movers